CORONA REMEDIES
|
The Current P/S Ratio of CORONA REMEDIES is 8.53.
| Share Price | ₹2,060.7 | Oct 14,2026 |
| Market Cap | ₹12,611.2 Cr | |
| Sales-TTM | ₹1,479.1 Cr | TTM-Consolidated Results |
| Price/Sales | 8.53x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of CORONA REMEDIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹12,611.2 Cr] as on Oct 14,2026
(/) Sales [ ₹1,479.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 8.53x ]
Thus, for CORONA REMEDIES , the investors are currently willing to pay '8.53 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of CORONA REMEDIES !
The chart below summarizes the trend in P/S Ratio of CORONA REMEDIES over the last five years.
Historical PS (Price/Sales) ratio chart of CORONA REMEDIES
PS Ratio Performance Analysis for CORONA REMEDIES
- CORONA REMEDIES 's p/e ratio for fiscal years ending Mar2026 to Mar2023 averaged 1.70x.
- CORONA REMEDIES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, CORONA REMEDIES 's p/e ratio peaked in Mar2026 at 6.78x.
- CORONA REMEDIES 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does CORONA REMEDIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| CORONA REMEDIES | 1,479.1 | 8.53 | 12,611.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.00 | 419,620.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 21.35 | 239,714.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.11 | 174,741.0 |
| CIPLA LTD | 28,324.4 | 3.74 | 106,061.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.05 | 101,339.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.53 | 96,243.6 |
| LUPIN LTD | 29,966.6 | 2.98 | 89,391.0 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.92 | 112,119.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.74 | 95,590.4 |
| LAURUS LABS LTD | 7,269.6 | 15.13 | 110,008.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CORONA REMEDIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.74x |
| Max industry PS | 21.35x |
| Median industry PS | 6.53x |
| Average industry PS | 7.83x |
You may also like the below Video Courses